How clinically important are non-D Rh antibodies?

Non-D Rh alloimmunisation is a relatively uncommon complication of pregnancy, occurring in only 0.33% of pregnancies in the study period. It can lead to significant fetal/neonatal morbidity (and may lead to mortality). The most severe outcomes (including perinatal deaths) were mostly associated with the compound antibodies anti-CD and anti-cE, or a non-D Rh antibody in conjunction with anti-D. This article is protected by copyright. All rights reserved.